Study identifies key risk factors driving MASLD across populations
Background and aims Metabolic dysfunction-associated steatotic liver disease (MASLD) affects approximately 32% of the US adult population. The…
Most commercially insured patients live with chronic conditions
The majority (57.5 percent) of commercially insured patients had at least one chronic condition in 2024. The average…
Scientists question the safety and efficacy of the diet for metabolic health
A study published in Science Advances by University of Utah Health researchers sheds light on the long-term effects…
Fatty acids found to be a primary driver of triple-negative tumor growth
A team from Huntsman Cancer Institute at the University of Utah (the U) has found that triple-negative breast…